Immunome Income Statement (2019-2026) | IMNM

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
2.36M4.26M3.56M3.83M1.03M2.36M2.91M2.74M2.93M4.01M
Operating items
Research & Development (Quarter)
4.51M4.38M8.08M5.72M5.22M4.25M3.91M5.72M3.82M9.64M15.37M29.08M37.20M47.89M36.87M40.45M49.19M50.77M46.38M59.88M
Selling, General & Administrative (Quarter)
3.21M3.46M3.58M3.21M3.31M3.54M2.92M4.32M4.38M8.04M6.00M6.98M9.53M10.45M10.69M10.04M10.95M12.09M12.95M18.25M
Other Operating Expenses (Quarter)
80.80M111.95M6.31M6.71M27.37M10.00M
Operating Expenses (Quarter)
7.72M7.84M11.65M8.93M8.53M7.79M6.83M10.04M8.20M98.48M133.33M42.37M53.43M85.71M47.56M50.49M60.14M72.86M59.33M78.14M
Operating Income (Quarter)
-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M-78.14M
EBIT (Quarter)
-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M-78.14M
Net income details
EBT (Quarter)
-7.72M-7.76M-11.75M-10.73M-11.93M-8.08M-4.57M-16.07M-15.83M-94.72M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-72.87M-244.25M-248.28M
Profit After Tax (Quarter)
-7.72M-7.84M-11.65M-8.92M-8.53M-8.42M-4.27M-5.56M-4.34M-92.63M-129.49M-36.12M-47.10M-80.25M-41.64M-43.40M-57.46M-69.90M-53.84M-73.13M
Income from Continuing Operations (Quarter)
-7.72M-7.76M-11.75M-10.73M-11.93M-8.08M-4.57M-16.07M-15.83M-94.72M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-72.87M-244.25M-248.28M
Consolidated Net Income (Quarter)
-7.72M-7.76M-11.75M-10.73M-11.93M-8.08M-4.57M-16.07M-15.83M-94.72M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-72.87M-244.25M-248.28M
Income towards Parent Company (Quarter)
-7.72M-7.76M-11.75M-10.73M-11.93M-8.08M-4.57M-16.07M-15.83M-94.72M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-72.87M-244.25M-248.28M
Preferred Dividend Payments (Quarter)
0.62M
Net Income towards Common Stockholders (Quarter)
-7.72M-7.85M-11.75M-10.73M-9.15M-7.79M-4.57M-16.07M-4.34M-92.63M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-72.87M-244.25M-248.28M
Additional items
EPS (Basic) (Quarter)
-0.65-0.68-0.97-0.88-0.75-0.64-0.38-1.32-0.36-4.67-2.57-1.44-1.93-1.42-0.57-0.81-1.16-0.83-2.16-2.19
EPS (Diluted) (Quarter)
-0.65-0.68-0.97-0.88-0.75-0.64-0.38-1.32-0.36-4.67-2.57-1.44-1.93-1.42-0.57-0.81-1.16-0.83-2.16-2.19
Shares Outstanding (Quarter)
11.93M11.54M12.12M12.13M12.13M12.13M12.18M12.20M12.20M19.84M51.54M59.94M60.21M58.64M79.41M87.01M87.96M87.35M113.14M113.27M
Shares Outstanding (Diluted) (Quarter)
11.93M11.54M12.12M12.13M12.13M12.13M12.18M12.20M12.20M19.84M51.54M59.94M60.21M58.64M79.41M87.01M87.96M87.35M113.14M113.27M
Shares Outstanding (Entity) (Quarter)
12.09M12.11M12.13M12.13M12.13M12.13M12.19M12.20M12.20M19.84M59.69M60.01M60.42M64.46M86.96M87.01M91.71M87.35M113.17M113.58M
EBITDA (Quarter)
-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M-78.14M
Interest Expenses (Quarter)
-0.09M0.10M1.80M3.40M0.29M0.10M10.30M11.20M0.06M0.10M46.22M65.61M0.30M0.26M23.82M41.77M0.01M184.91M170.14M